(Reuters) -German science and technology group Merck is open to more acquisitions for its Life Science business after ...

Merck KGaA cut its mid-term sales growth target for its health-care division after a number of high-profile drug trial ...

The German company said booming artificial-intelligence demand would help its electronics sales grow faster than previously ...

Merck KGaA lowered its medium-term outlook for its healthcare and life-science segment due to China challenges and recent ...

US pharmaceutical firm Merck & Co plans to build a £1 billion ... at the heart of the city’s life sciences “cluster”. The Financial Times reported that the company expects to employ ...

North Carolina Agricultural and Technical State University and Merck (NYSE: MRK), known as MSD outside of the United States ...

Oct. 15, 2024 — Researchers have discovered seven new species of tree frogs that make otherworldly calls in the rainforests of Madagascar. Their strange, ... Tube Sock-Like Skunk Covers More ...

Merck (NYSE: MRK) is a top pharmaceutical company coming off a good quarter that shows it is growing its top and bottom lines. Even with that growth, the stock still trades at a fairly modest ...

Merck & Co. has picked up options on two Evaxion Biotech vaccine candidates, paying $3.2 million and dangling more than $1 billion in milestones for the chance to pick up preclinical prospects ...

Sept 25 (Reuters) - Merck (MRK.N), opens new tab said on Wednesday a combination of its experimental drug and blockbuster therapy Keytruda failed a late-stage trial testing it in previously ...

Nuclear Medicine Technologists operate equipment that detects and maps radioactive drugs within a patient’s body to create diagnostic images. The images are ... Food & Flavor Chemists use their life ...

Nuclear Medicine Technologists operate equipment that detects and maps radioactive drugs within a patient’s body to create diagnostic images. The images are ... Flavor Chemists use their life sciences ...